Acquisition of Data, Blood, and Tumor Tissue Samples From Patients With Gastrointestinal Cancer

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Background: \- Gastrointestinal cancers can occur in the throat, stomach, gallbladder, liver, pancreas, and colon. Researchers are interested in evaluating how active the immune system is in trying to fight the cancer by studying blood and tumor tissue donated from individuals who have been diagnosed with gastrointestinal cancers.

Objectives: \- To collect blood and tumor samples from individuals who have been diagnosed with gastrointestinal cancers in order to study the immune system s response to the cancer.

Eligibility: \- Individuals at least 18 years of age who have been diagnosed with throat, stomach, gallbladder, liver, pancreatic, or colon cancer, and are scheduled to be treated at the National Institutes of Health.

Design: * The study will require at least one but no more than four visits to the National Institutes of Health Clinical Center. * Participants will be screened with a physical examination and medical history, and will provide a baseline blood sample for study. * Participants will provide additional blood samples 2 and 4 months after the baseline sample, as well as a final sample at the completion of the treatment protocol. * Participants will provide tumor tissue samples only if they undergo a surgical procedure related to the treatment for their gastrointestinal cancer. * No treatment will be provided as part of this protocol.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Individuals 18 years of age and older

• Individuals with a diagnosis of cancer

• Individuals must be able to understand and willing to sign a written informed consent document

Locations
United States
Maryland
National Institutes of Health Clinical Center
RECRUITING
Bethesda
Contact Information
Primary
Stephanie N Hicks
hickssn2@nih.gov
(240) 760-6159
Backup
Tim F Greten, M.D.
gretentf@mail.nih.gov
(240) 760-6114
Time Frame
Start Date: 2011-03-02
Participants
Target number of participants: 550
Treatments
1/ Cohort 1
Individuals with a diagnosis of cancer
Related Therapeutic Areas
Sponsors
Leads: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov